FDA Inspection
Northland Nuclear Medicine, LLCNorthland Nuclear Medicine, LLC – FDA Inspection, Jun 7, 2019
Record Details
This FDA Inspection record concerns Northland Nuclear Medicine, LLC, with an inspection on June 7, 2019, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · 1d9a3582-f77c-4de9-b9c2-80c2cd2bbb27
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1092563
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 212.30(b)Equipment procedures
- 21 CFR 212.50Adequate controls (general)
- 21 CFR 212.50(b)Master Production and Control Records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Northland Nuclear Medicine, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 13, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Northland Nuclear Medicine, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.